MP-V1 from the Venom of Social Wasp Vespula vulgaris Is a de Novo Type of Mastoparan that Displays Superior Antimicrobial Activities
Yangseon Kim,
Minky Son,
Eun-Young Noh,
Soonok Kim,
Changmu Kim,
Joo-Hong Yeo,
Chanin Park,
Keun Woo Lee,
Woo Young Bang
Affiliations
Yangseon Kim
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Minky Son
Division of Applied Life Science (BK21 Plus) & Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 660-701, Korea
Eun-Young Noh
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Soonok Kim
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Changmu Kim
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Joo-Hong Yeo
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Chanin Park
Division of Applied Life Science (BK21 Plus) & Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 660-701, Korea
Keun Woo Lee
Division of Applied Life Science (BK21 Plus) & Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 660-701, Korea
Woo Young Bang
National Institute of Biological Resources (NIBR), Environmental Research Complex, Incheon 404-708, Korea
Mastoparans from the venom of social wasps have attracted considerable attention as effective antibiotic candidates. In this study, mastoparan V1 (MP-V1) from Vespula vulgaris was first disclosed to have a peptide amino acid sequence distinct from typical mastoparans and its biochemical properties and antimicrobial effects were compared with those of typical mastoparans MP-L, -X(V) and -B. Circular dichroism (CD) spectroscopy revealed that MP-V1 and -X(V) form more stable α-helical conformations in lipid membrane-like environments than MP-L and -B. In parallel, these two also showed more effective antimicrobial activities against the pathogens than did MP-L and -B. Although MP-V1 had a less stable α-helical conformation than MP-X(V), it showed stronger antimicrobial effects against Streptococcus mutans and Salmonella enterica than MP-X(V). In the meantime, analysis of hemolytic activity revealed a range of doses (~50 μM) that exhibited little potent cytotoxicity on human erythrocytes. Finally, the atypical MP-V1 peptide amino acid sequence provided important clues to understanding its antimicrobial mechanism from a structural perspective. Therefore, it has been concluded that MP-V1 is a de novo type of mastoparan with superior antimicrobial activities against both pathogenic bacteria and fungi, which may be useful in developing multipurpose antimicrobial drugs against infectious diseases.